Chia-Cheng Li

Citeras av

	Alla	Sedan 2019
Citat	327	243
h-index	9	9
i10-index	9	8

2013201420152016201720182019202020212022202320243 9 8 17 17 21 27 36 46 50 65 19

Offentlig åtkomst

Visa alla

1 artikel

0 artiklar

tillgänglig

inte tillgänglig

Enligt krav från finansiärer

Medförfattare

Asma AlmazyadKing Saud bin Abdulaziz University for Health and ScienceVerifierad e-postadress på ksau-hs.edu.sa
Daniel J. DeAngeloProfessor of Medicine, Harvard Medical SchoolVerifierad e-postadress på dfci.harvard.edu
Amit VermaProfessor, Oncology, Albert Einstein College of Medicine, Montefiore Medical CenterVerifierad e-postadress på einsteinmed.edu
Guillermo Garcia-ManeroMD Anderson Cancer CenterVerifierad e-postadress på mdanderson.org
Aditi BhattacharyaAssistant Professor Oral and Maxillofacial Surgery, NYUVerifierad e-postadress på nyu.edu
Mary TonerConsultant pathologist Dublin Dental University HospitalVerifierad e-postadress på tcd.ie
Javier Portilla RobertsonUNAMVerifierad e-postadress på fo.odonto.unam.mx
Ingrid CarvoHarvard UniversityVerifierad e-postadress på hsdm.harvard.edu
Wanying ZhaoCuris IncVerifierad e-postadress på curis.com
Mehdi NikkhahAssociate Professor of Biomedical Engineering, Arizona State UniversityVerifierad e-postadress på asu.edu
Mahshid KharazihaAssociate professor of Materials Engineering, Isfahan University of TechnologyVerifierad e-postadress på cc.iut.ac.ir
Wolfram GoesslingProfessor of Medicine, Harvard Medical SchoolVerifierad e-postadress på hms.harvard.edu
Kimberly D TremblayVerifierad e-postadress på umass.edu
Arkadi ShwartzBrigham and Women Hospital, Harvard Medical schoolVerifierad e-postadress på bwh.harvard.edu
Trista E NorthAssociate Professor, Harvard Medical SchoolVerifierad e-postadress på childrens.harvard.edu
Kyle LaBellaGenentechVerifierad e-postadress på gene.com
Muath Aldosari, BDS MPH DMScKing Saud University, Harvard School of Dental MedicineVerifierad e-postadress på hsdm.harvard.edu
Sang E ParkHarvard School of Dental MedicineVerifierad e-postadress på hsdm.harvard.edu
Jeff CW. WangClinical Associate Professor, University of Michigan School of DentistryVerifierad e-postadress på umich.edu
David M. KimHarvard School of Dental MedicineVerifierad e-postadress på hsdm.harvard.edu

Följ

Chia-Cheng Li

Harvard University

Verifierad e-postadress på hsdm.harvard.edu - Startsida

Immuno-oncology Biomarker Pathology Higher Education


Titel Sortera efter citat Sortera efter år Sortera efter titel	Citeras av Citeras av	År
Oral cancer: genetics and the role of precision medicine CC Li, Z Shen, R Bavarian, F Yang, A Bhattacharya Dental Clinics 62 (1), 29-46, 2018	81	2018
Mucosal pigmentation caused by imatinib: report of three cases CC Li, SM Malik, BF Blaeser, WJ Dehni, SP Kabani, N Boyle, M Toner, ... Head and neck pathology 6, 290-295, 2012	75	2012
Primordial odontogenic tumour: report of two cases A Almazyad, CC Li, ROC Tapia, JP Robertson, D Collette, SB Woo Histopathology 72 (7), 1221-1227, 2018	29	2018
Phase 1/2a study of the IRAK4 inhibitor CA-4948 as monotherapy or in combination with azacitidine or venetoclax in patients with relapsed/refractory (R/R) acute myeloid … G Garcia-Manero, ES Winer, DJ DeAngelo, SR Tarantolo, DA Sallman, ... Journal of Clinical Oncology 40 (16_suppl), 7016-7016, 2022	22	2022
Rare mandibular surgical ciliated cysts: report of two new cases CC Li, DM Feinerman, KD MacCarthy, SB Woo Journal of Oral and Maxillofacial Surgery 72 (9), 1736-1743, 2014	17	2014
Architectural alterations in oral epithelial dysplasia are similar in unifocal and proliferative leukoplakia CC Li, S Almazrooa, I Carvo, A Salcines, SB Woo Head and neck pathology 15, 443-460, 2021	16	2021
Benign alveolar ridge keratosis: clinical and histopathologic analysis of 167 cases A Almazyad, CC Li, SB Woo Head and neck pathology 14, 915-922, 2020	11	2020
S129: TAKEAIM LEUKEMIA-a phase 1/2A study of the IRAK4 inhibitor emavusertib (CA-4948) as monotherapy or in combination with azacitidine or venetoclax in relapsed/refractory … G Garcia-Manero, ES Winer, DJ DeAngelo, S Tarantolo, DA Sallman, ... HemaSphere 6, 30-31, 2022	10	2022
Microfabrication of cell-laden hydrogels for engineering mineralized and load bearing tissues CC Li, M Kharaziha, C Min, R Maas, M Nikkhah Engineering Mineralized and Load Bearing Tissues, 15-31, 2015	10	2015
Estrogen acts through estrogen receptor 2b to regulate hepatobiliary fate during vertebrate development S Chaturantabut, A Shwartz, MK Garnaas, K LaBella, CC Li, KJ Carroll, ... Hepatology 72 (5), 1786-1799, 2020	9	2020
Dendritic cell neurofibroma with pseudorosettes: A clinicopathologic and immunohistochemical study of five intraoral cases MA Lerman, CC Li, SB Woo Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 117 (2), 221-226, 2014	9	2014
Intraoral Spitz nevus: case report and literature review CC Li, TJ Harrist, VL Noonan, SB Woo Oral surgery, oral medicine, oral pathology and oral radiology 117 (4), e320-4, 2014	9	2014
Crohn’s disease initiated with extraintestinal features J Chang, CC Li, M Achtari, E Stoufi BMJ Case Reports CP 12 (4), e229916, 2019	6	2019
WNT SIGNALING IN ORAL CANCER INITIATING CELLS R MENON, CC LI, MZ LI Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 124 (3), e202, 2017	6	2017
Understanding the pathobiology of head and neck squamous cell carcinoma CC Li, SB Woo Current Oral Health Reports 1, 196-203, 2014	4	2014
Open-label, dose-escalation, and expansion trial of CA-4948 in combination with ibrutinib in patients with relapsed or refractory hematologic malignancies. E Joffe, GS Nowakowski, HW Tun, AC Rosenthal, MA Lunning, ... Journal of Clinical Oncology 40 (16_suppl), 7575-7575, 2022	3	2022
Understanding pedagogical approaches on student learning styles CC Li, MA Aldosari, SE Park Ann Dent Oral Health 4 (1), 1039-45, 2021	3	2021
Molecular characterization of clinical response in relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndrome patients treated with single agent emavusertib KH Metzeler, ES Winer, U Platzbecker, A Verma, DJ DeAngelo, ... Blood 140 (Supplement 1), 9048-9049, 2022	2	2022
CTIM-34. PRELIMINARY SAFETY AND EFFICACY DATA ON TWO PATIENTS WITH RELAPSED/REFRACTORY CNS LYMPHOMA TREATED WITH EMAVUSERTIB (CA-4948) AND IBRUTINIB COMBINATION: A SUBSET … M Iqbal, H Tun, E Joffe, C Grommes, G Nowakowski, M Lunning, ... Neuro-Oncology 24 (Suppl 7), vii68, 2022	1	2022
P473: DEVELOPMENT OF POTENTIAL BIOMARKERS FOR IRAK4 INHIBITOR EMAVUSERTIB IN HUMAN ACUTE MYELOID LEUKEMIA A Ugolkov, M Pilichowska, CC Li, RC Hok, M Samson, M Lane, ... HemaSphere 6, 372-373, 2022	1	2022

Systemet kan inte utföra åtgärden just nu. Försök igen senare.

Artiklar 1–20

Citat per år

Dubblettcitat

Sammanfogade citat

Lägg till medförfattareMedförfattare

Följ

Citeras av

Medförfattare